Digital biomarkers offer non-invasive, objective, and continuous measurements of physiological and behavioral parameters, collected via wearable sensors. They can provide a deeper understanding of disease progression, treatment effectiveness, and patient response in real-world settings, facilitating more robust and patient-centric research, and can be a key tool in clinical trials by serving as digital endpoints.
By harnessing the power of digital health technologies and digital biomarkers, researchers and healthcare practitioners gain access to new opportunities in remote monitoring, personalized medicine, early detection, and cost-effective data collection. The above can enhance the efficiency and accuracy of clinical studies, and holds the promise of more personalized and effective interventions, ultimately improving the quality of healthcare and advancing medical knowledge.
Leveraging the ability of our EmbracePlus wearable to be worn on different parts of the body thanks to its various form factors, our actigraphy offering covers dozens of digital measures, from gait analysis to activity.
Empatica’s digital biomarkers and a range of partner algorithms come together in our Platform, allowing clinical trial sponsors to choose from 300+ reliable digital measures.
Meet all your physiological data collection needs using one wearable and platform, reducing operational costs and the burden on both patients and sites.
Our team can help develop digital biomarkers for use in your research or practice. Empower your research with the transformative potential of digital biomarkers through a strategic partnership with Empatica and guidance through all steps of the validation process.
Case Study:
Discover how we partnered with Takeda to create a novel digital endpoint around sweat detection for Fabry disease patients.
Proven applications in:
